Posted on
Oct 2, 2026
Billing G2211 With Modifier 25 Alongside Annual Wellness Visits in 2026: The Operations Playbook
Billing G2211 With Modifier 25 Alongside Annual Wellness Visits in 2026: The Operations Playbook
Prepared for practice administrators and chief medical officers by the clinical consulting team at Scribing.io. This playbook reflects the CY2025 Medicare Physician Fee Schedule policy change, which continues in 2026, along with current audit patterns for Modifier 25. Statements of CMS policy are paraphrased, so confirm specifics against your MAC's local guidance before changing charge rules.
One rule change reshaped same-day primary care economics. Since January 1, 2025, CMS pays the G2211 visit complexity add-on when the office/outpatient E/M carries Modifier 25, but only when the other same-day service is an Annual Wellness Visit, a vaccine administration, or a Medicare Part B preventive service. Scribing.io builds Clinical-Grade Scribing workflows around that narrow exception, so practices capture the revenue without creating the documentation gaps that drive Modifier 25 clawbacks.
The 2026 regulatory baseline for G2211 and Modifier 25
The same-day gating rule explained
Clinical logic masterclass case: AWV plus decompensated HFrEF
Segregating AWV content from the problem E/M
The human-attested Clinical Logic Bridge
Building the claim line by line
SB 1120 audit packaging and clawback defense
EMR injection through DOM and FHIR
Practice administrator operations checklist
Financial model for the CMO
Frequently asked questions from billing teams
The 2026 Regulatory Baseline for G2211 and Modifier 25
G2211 is an add-on to office/outpatient E/M codes 99202–99215. It recognizes the cost of being the continuing focal point for a patient's care, or of providing ongoing care for a single serious or complex condition. The code describes a longitudinal relationship. It does not describe the intensity of a single visit.
The original 2024 policy made G2211 non-payable whenever the base E/M was reported with Modifier 25. In the CY2025 Physician Fee Schedule final rule, CMS carved out an exception for preventive services. That exception remains the operative policy for 2026 claims.
G2211 payment status by year and same-day context | |||
Policy Year | E/M Without Modifier 25 | E/M-25 With AWV, Vaccine Admin, or Part B Preventive | E/M-25 With Minor Procedure |
|---|---|---|---|
2024 | Payable | Not payable | Not payable |
2025 | Payable | Payable | Not payable |
2026 | Payable | Payable | Not payable |
Modifier 25 scrutiny has not eased. The OIG has repeatedly flagged Modifier 25 as an area of improper payment, and MACs use Targeted Probe and Educate reviews on high-volume billers. A practice that adds G2211 to more Modifier 25 claims should expect closer review of those claims.
The Same-Day Gating Rule: When G2211 Survives Modifier 25
Operationally, G2211 is gated by what else appears on the claim. The Scribe separates the problem-oriented E/M narrative from G0438/G0439 content. It pairs G2211 with Modifier 25 only when a same-day AWV, vaccine administration, or Part B preventive service is documented.
Gating logic applied before G2211 is suggested | |||
Same-Day Service Documented | Example Codes | G2211 on E/M-25 Line? | Scribe Action |
|---|---|---|---|
Initial AWV | G0438 | Yes | Suggest G2211 if longitudinal criteria are met |
Subsequent AWV | G0439 | Yes | Suggest G2211 if longitudinal criteria are met |
Vaccine administration | G0008, G0009, G0010, 90471 | Yes | Suggest G2211; confirm product and admin lines |
Part B preventive service | G0442/G0443, G0444, G0446 | Yes | Suggest G2211; verify preventive frequency limits |
Minor procedure | 20610, 11102, 17110 | No | Suppress G2211; flag the reason for the coder |
No other service | E/M only | N/A (no Modifier 25) | Suggest G2211 without Modifier 25 |
Gating is necessary, not sufficient. A preventive service on the same claim only makes G2211 eligible for payment. The record must still show a continuing relationship or ongoing management of a serious or complex condition.
Clinical Logic Masterclass: Subsequent AWV With Decompensated HFrEF
The patient is a Medicare beneficiary scheduled for a subsequent AWV (G0439). During the visit, the physician also manages decompensated heart failure with reduced ejection fraction (echo LVEF 35%) and adjusts diabetes medications after a failed ACE inhibitor trial. PCV20 is administered during the same encounter.
What the Physician Actually Did
Completed the subsequent AWV elements: updated the health risk assessment, medical and family history, and list of current providers and suppliers. Also documented vitals and a cognitive screen, and updated the written screening schedule.
Assessed worsening HFrEF symptoms: 3.2 kg weight gain over 10 days, two-pillow orthopnea, and 2+ bilateral pitting edema, with no rest dyspnea and no hypoxia.
Addressed the ACE inhibitor failure: persistent dry cough on lisinopril, documented as an adverse effect. The plan is a transition to sacubitril/valsartan after the required 36-hour ACE inhibitor washout.
Adjusted diabetes therapy for overlap: started an SGLT2 inhibitor for both glycemic control and HFrEF guideline-directed medical therapy (GDMT), and reduced the sulfonylurea dose to lower hypoglycemia risk.
Increased loop diuretic dosing temporarily: ordered a basic metabolic panel within one week to monitor potassium, creatinine, and volume status alongside the new SGLT2 inhibitor.
Coordinated with the cardiologist: requested an expedited follow-up visit and discussed whether to start a mineralocorticoid receptor antagonist once potassium is confirmed stable.
Administered PCV20 per ACIP guidance: documented lot number, site, VIS edition date, and the administering staff member.
Why This Encounter Supports 99214
Medical decision making reaches moderate complexity on two elements. Problems include one chronic illness with exacerbation (HFrEF) plus a second chronic illness requiring treatment adjustment (type 2 diabetes). Risk is moderate because of prescription drug management across four agents.
The scribe does not level this visit by time. AWV minutes cannot count toward E/M time, so MDM is the defensible leveling basis whenever an AWV is billed on the same day. If the exacerbation were severe, with signs of imminent hospitalization, the scribe would surface 99215 for physician review.
Diagnosis Mapping
ICD-10-CM codes linked to each claim line | ||
Clinical Finding | ICD-10-CM | Linked Claim Line |
|---|---|---|
Wellness exam with abnormal findings | G0439 | |
Acute on chronic systolic heart failure | I50.23 | 99214-25, G2211 |
Type 2 diabetes with hyperglycemia | E11.65 | 99214-25, G2211 |
Adverse effect of ACE inhibitor, initial encounter | T46.4X5A | 99214-25 |
Long-term use of oral hypoglycemic drugs | Z79.84 | 99214-25 |
Encounter for immunization | 90677, G0009 |
Diagnosis pointer discipline prevents denials. Z00.01 should never point to the E/M line, and I50.23 should never be the sole pointer on G0439. Mixing these pointers is one of the most common triggers for automated Modifier 25 edits.
Segregating G0439 Content From the Problem-Oriented E/M Narrative
A Modifier 25 claim must contain an E/M note that would stand on its own if the AWV documentation were removed. Ambient Clinical Intelligence captures one continuous conversation. Revenue integrity depends on splitting that conversation into two clinically distinct documents.
How Medical AI Scribing routes each transcript segment | ||
Transcript Content | Routed To | Rationale |
|---|---|---|
Health risk assessment responses | G0439 note | Required AWV element |
Cognitive screen and functional status | G0439 note | Required AWV element |
Screening schedule and preventive counseling | G0439 note | Personalized prevention plan |
Orthopnea, edema, weight trend | E/M note: HPI and exam | Problem-oriented work beyond the AWV |
ACE cough history and ARNI transition | E/M note: assessment and plan | Prescription drug management |
SGLT2i start and sulfonylurea reduction | E/M note: assessment and plan | Chronic illness treatment adjustment |
Blood pressure and weight | Both, cited once | Shared vitals referenced, not duplicated |
PCV20 consent and administration | Immunization record | Supports 90677 and G0009 |
Shared data is cited, not copied. The E/M note references the vital signs recorded in the AWV rather than duplicating them. Duplicated text is a known signal in clone-note audits.
Chief complaint is problem-specific. The E/M note opens with "worsening dyspnea and edema," not "Annual Wellness Visit."
Medication reconciliation stays split. The AWV updates the medication list, and the E/M note documents why each change was made.
Specialty-specific segregation templates are available in the Specialty Clinical Playbook Library, including variants for internal medicine and family medicine.
The Human-Attested Clinical Logic Bridge for G2211
The most frequent G2211 audit weakness is a note that never explains the longitudinal relationship. Merry AI Scribe generates a Clinical Logic Bridge, a short structured attestation that links today's decisions to the ongoing management of CHF and diabetes. The physician reviews, edits, and signs it before the charge is released.
Bridge Components for This Encounter
Continuity statement: the practice has been the patient's continuing focal point for HFrEF and diabetes care for four years and coordinates all specialty input.
GDMT titration pathway: today's ARNI transition and SGLT2 inhibitor start are steps toward four-pillar GDMT, and MRA initiation is pending potassium results.
Cardiology coordination link: an expedited cardiology referral was placed, and shared decisions on MRA timing and repeat echo are documented.
Medication risk surveillance: the note records the plan to monitor hyperkalemia, volume depletion with diuretic plus SGLT2 inhibitor, euglycemic DKA, and hypoglycemia with the reduced sulfonylurea.
Forward follow-up plan: BMP within seven days, a nurse weight check call in 72 hours, and a return visit in two weeks for titration.
Attestation is the control point. The bridge is drafted from the transcript, but it becomes part of the legal record only after the clinician signs it. That human attestation is what separates defensible G2211 documentation from template boilerplate.
Building the Claim Line by Line
The scribe assembles the claim as G0439 + 99214-25 + G2211 + PCV20 product + Part B administration. Each line has its own diagnosis pointers and its own cost-sharing profile.
Final claim structure for the masterclass encounter | ||||
Line | Code | Modifier | Dx Pointer | Patient Cost Sharing |
|---|---|---|---|---|
1 | G0439 (subsequent AWV) | None | Z00.01 | None |
2 | 99214 (established E/M) | 25 | I50.23, E11.65, T46.4X5A, Z79.84 | Deductible and 20% coinsurance |
3 | G2211 (complexity add-on) | None | I50.23, E11.65 | Deductible and 20% coinsurance |
4 | 90677 (PCV20 product) | None | Z23 | None |
5 | G0009 (pneumococcal admin) | None | Z23 | None |
G2211 belongs on the E/M line, never on the AWV. It is an add-on to 99202–99215 only.
Modifier 25 attaches to 99214, not to G0439. Placing it on the wrong line triggers an automatic edit.
Use G0009 for Medicare pneumococcal administration, not 90471. Using 90471 for a Part B pneumococcal vaccine is a common source of avoidable rejections.
Tell the patient about coinsurance in advance. The E/M and G2211 lines generate a bill on a visit the patient may assume is free, which drives complaints and write-offs.
Code-level references for adjacent diagnoses are maintained in the ICD-10 clinical reference.
SB 1120 Audit Packaging and Clawback Defense
California SB 1120 requires that medical necessity decisions by health plans and disability insurers be made by licensed clinicians, not by algorithms alone. Practices are increasingly asked to show the same standard on their side: that a human clinician made the coding and clinical decisions. Scribing.io packages every flagged encounter into an SB 1120 audit report, and details are in the AI scribe law tracker.
Contents of the encounter audit packet | |
Artifact | Purpose in an Audit or Appeal |
|---|---|
Segregated G0439 and E/M notes | Proves the E/M was significant and separately identifiable |
Signed Clinical Logic Bridge | Supports G2211 longitudinal relationship criteria |
MDM element mapping | Shows the problems, data, and risk behind 99214 |
Gating rule log | Documents why G2211 was allowed with Modifier 25 |
Human attestation timestamps | Shows clinician review before charges were released |
Edit history and source transcript hash | Preserves integrity of the record |
Clawback defense starts at signature. When a MAC or commercial payer requests records, the packet is exported as a single PDF with the gating and attestation logs attached. Appeals that would otherwise take hours of chart reconstruction can then be filed the same day.
EMR Injection: DOM and FHIR Pathways
Two delivery pathways exist for moving the individualized problem note and charges into the EMR. DOM injection writes directly into the browser-rendered EMR fields. FHIR-based write-back uses standardized resources where the vendor supports them.
Comparison of EMR delivery methods | ||
Capability | DOM Injection | FHIR Write-Back |
|---|---|---|
Note placement | Populates native note sections directly | DocumentReference or Composition resource |
Charge capture | Fills charge entry fields for coder review | Depends on vendor ChargeItem support |
Deployment time | Days, with no vendor interface build | Weeks to months, with vendor approval |
Separate note segregation | Two notes injected into two encounter sections | Two resources linked to one encounter |
Audit trail | Logged at the Scribing.io layer | Logged in both systems |
Vendor-specific configuration notes are listed in the EHR Clinical Integration Directory and the Scribing.io integration reference. Both cover how to keep the AWV and E/M documentation in separate encounter sections.
Practice Administrator Operations Checklist
Audit your 2025 claims history for E/M-25 lines with same-day AWV or vaccine administration that were billed without G2211. This shows how much revenue has been missed.
Update charge master rules: suppress G2211 on E/M-25 lines when a minor procedure is billed the same day.
Retire combined AWV and problem templates. One merged note cannot support Modifier 25.
Train clinicians on MDM leveling. Time-based leveling is unreliable when AWV minutes overlap with problem-focused work.
Script the coinsurance conversation for front-desk staff: "Your wellness visit has no cost, but managing your heart failure today is a separate service."
Monitor your G2211 attachment rate by clinician monthly. Rates far above peers invite review.
Keep SB 1120 audit packets for at least the full Medicare record retention period.
Financial Model for the CMO
G2211 pays roughly $16 per line at 2026 national rates before locality adjustment. That amount is small per



